j a c c . 2 0 1 5 . 1 0 . 0 0 5 P U B L I S H E D B Y E L S E V I E R ACC/AHA Task Force Members Jonathan L. Halperin, MD, FACC, FAHA, Chair Glenn N. Levine, MD, FACC, FAHA, Chair-Elect Jeffrey L. Anderson, MD, FACC, FAHA, Immediate Past Chair** Nancy M. Albert, PhD, RN, FAHA** Sana M. Al-Khatib, MD, MHS, FACC, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD, FACC, FAHA Ralph G. Brindis, MD, MPH, MACC Joaquin E. Cigarroa, MD, FACC Lesley H. Curtis, PhD, FAHA Lee A. Fleisher, MD, FACC, FAHA Federico Gentile, MD, FACC Samuel Gidding, MD, FAHA Mark A. Hlatky, MD, FACC John Ikonomidis, MD, PhD, FAHA Jose Joglar, MD, FACC, FAHA Richard J. Kovacs, MD, FACC, FAHA** E. Magnus Ohman, MD, FACC** Susan J. Pressler, PhD, RN, FAHA Frank W. Sellke, MD, FACC, FAHA** Win-Kuang Shen, MD, FACC, FAHA** Duminda N. Wijeysundera, MD, PhD **Former Task Force member; current member during the writing effort. TABLE OF CONTENTS PREAMBLE 1236 1. INTRODUCTION 1237 1.1. Methodology and Evidence Review 1237 1.2. Organization of the GWC 1338 1.3. Review and Approval 1238 2. CULPRIT ARTERY ONLY VERSUS MULTIVESSEL PCI 1239 3. 